Non-neutralizing antibodies and limitations of serologic testing for severe acute respiratory syndrome coronavirus 2 in patients receiving immunoglobulin replacement products

Detalles Bibliográficos
Autores principales: Manian, Deepti Vellaichamy, Jensen, Chelsee, Theel, Elitza S., Mills, John R., Joshi, Avni
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834008/
https://www.ncbi.nlm.nih.gov/pubmed/33232829
http://dx.doi.org/10.1016/j.anai.2020.11.009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834008/
https://www.ncbi.nlm.nih.gov/pubmed/33232829
http://dx.doi.org/10.1016/j.anai.2020.11.009

Ejemplares similares